DaVita Inc. (NYSE:DVA) Stock Holdings Trimmed by Dark Forest Capital Management LP

Dark Forest Capital Management LP lowered its holdings in shares of DaVita Inc. (NYSE:DVA) by 42.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,049 shares of the company’s stock after selling 1,510 shares during the period. Dark Forest Capital Management LP’s holdings in DaVita were worth $306,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Invesco Ltd. grew its holdings in DaVita by 20.9% during the fourth quarter. Invesco Ltd. now owns 1,589,545 shares of the company’s stock worth $237,716,000 after acquiring an additional 275,284 shares during the period. JPMorgan Chase & Co. grew its stake in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock worth $99,846,000 after purchasing an additional 92,014 shares during the last quarter. Amundi grew its stake in shares of DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock worth $68,726,000 after purchasing an additional 240,126 shares during the last quarter. Epoch Investment Partners Inc. acquired a new position in shares of DaVita in the 4th quarter worth approximately $55,100,000. Finally, KBC Group NV grew its stake in shares of DaVita by 0.8% in the 4th quarter. KBC Group NV now owns 316,155 shares of the company’s stock worth $47,281,000 after purchasing an additional 2,636 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

DaVita stock opened at $140.64 on Tuesday. The firm’s 50 day simple moving average is $146.22 and its 200-day simple moving average is $155.10. The company has a market cap of $11.25 billion, a P/E ratio of 13.09, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a fifty-two week low of $131.27 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DVA shares. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, StockNews.com raised shares of DaVita from a “hold” rating to a “buy” rating in a research note on Friday. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.